Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial.
about
Nicotine receptor partial agonists for smoking cessationVarenicline for smoking cessation: a narrative review of efficacy, adverse effects, use in at-risk populations, and adherenceOrthosteric and Allosteric Ligands of Nicotinic Acetylcholine Receptors for Smoking CessationSmoking cessation and reduction in people with chronic mental illnessSmoking Use and Cessation Among People with Serious Mental IllnessSmoking cessation and the cardiovascular patientRisk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysisThe Past, Present, and Future of Nicotine Addiction TherapyVarenicline as a Cause of Suicidal OutcomesVarenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized TrialVarenicline and risk of psychiatric conditions, suicidal behaviour, criminal offending, and transport accidents and offences: population based cohort studyTreating Smokers in Substance Treatment With Contingent Vouchers, Nicotine Replacement and Brief Advice Adapted for Sobriety SettingsnAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas.Rationale and design of a randomized controlled trial of varenicline directly observed therapy delivered in methadone clinicsUse of varenicline for smoking cessation treatment in UK primary care: an association rule mining analysis.Tobacco use treatment in primary care patients with psychiatric illness.Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo-controlled trial.An association between the use of hypnotics and quit status in the treatment of nicotine dependence with varenicline in bipolar disorder.AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacologyVarenicline for smoking cessation in people with schizophrenia: systematic review and meta-analysis.Smoking cessation in Asians: focus on vareniclineTobacco use in bipolar disorderProtocol for CHANGE: a randomized clinical trial assessing lifestyle coaching plus care coordination versus care coordination alone versus treatment as usual to reduce risks of cardiovascular disease in adults with schizophrenia and abdominal obesitTreatment of tobacco use disorders in smokers with serious mental illness: toward clinical best practicesDesign and Synthesis of Nicotinic Acetylcholine Receptor Antagonists and their Effect on Cognitive Impairment.Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders.Expanding Cessation Pharmacotherapy Via Videoconference Educational Outreach to Prescribers.Interventions to Address Medical Conditions and Health-Risk Behaviors Among Persons With Serious Mental Illness: A Comprehensive Review.Cancer screening, prevention, and treatment in people with mental illness.The use of peer mentors to enhance a smoking cessation intervention for persons with serious mental illnesses.Cigarette smoking and interest in quitting among overweight and obese adults with serious mental illness enrolled in a fitness intervention.Pharmacotherapy of Co-Occurring Schizophrenia and Substance Use DisordersCost-effectiveness of smoking cessation treatment initiated during psychiatric hospitalization: analysis from a randomized, controlled trialNicotine Replacement Therapy as a Maintenance Treatment.Use of Varenicline in Smokeless Tobacco Cessation: A Systematic Review and Meta-Analysis.Abstinence and Use of Community-Based Cessation Treatment After a Motivational Intervention Among smokers with Severe Mental Illness.Drug repurposing and emerging adjunctive treatments for schizophrenia.A combined analysis of worldwide studies demonstrates an association between bipolar disorder and tobacco smoking behaviors in adults.Pharmacological treatment of schizophrenia with comorbid substance use disorder.
P2860
Q24185773-1800ABA8-9146-40F2-8891-39F39482FA1DQ26751374-0D4DF0A0-A206-42AA-B9E3-87FF08AA96FEQ26774830-15E8C57A-452B-4271-B68A-96D32498824AQ26782639-303CEA8A-5FFF-4EFF-B520-3A1D947678F7Q26785461-155440B8-4886-46CB-8D6D-EFBE38684235Q28082695-394CEE48-AF6E-494F-994E-D6C127673F8EQ28083649-9F3CD000-0E86-4D7C-A632-7A65F5EF0CCFQ28088508-9400F899-B6BF-4D40-98C3-A637ED14183BQ28255130-13BE46C2-4BD7-4AC6-9096-F644BA18C966Q28552053-C106A334-3FEB-42D0-9A55-C0DFBBA1A47CQ28646213-3F0060AC-330B-4EDA-BC5B-2FD00680A232Q29014090-C5C0FA99-A94C-43DB-83BE-91A954AB96CCQ30362464-D1B8E9BE-ACE4-4F42-B47D-028A641BDFE2Q30379171-9AA11E64-077F-4B9D-8319-91C16EE51033Q33854297-FE6E77F4-C355-4118-A01B-E87E49FE2B9CQ34318521-ECEA096C-09C5-457C-9A18-371A39E96507Q34725293-3599D4B4-899D-428D-9792-CA28F82AFD73Q34992065-9BF6EDB0-716E-4A34-85C1-FD17378385B4Q35130719-81706F0D-BEAC-4480-A816-59C947D48700Q35223957-D6C090C7-72C1-46CF-A19F-0AF03D262C04Q35302795-D912AD8E-6BA5-4093-8A6F-9FB66CC0286CQ35491463-D7BB2B1E-123D-476C-93FD-F3C0515EA856Q35579231-5A202EE4-6EF7-4B6D-A315-0B987D3454C0Q35700367-605C747A-2167-432F-B2D6-E066F961AED8Q35701489-3BB8FA44-7B4F-486E-BD42-70488AD523FEQ35733853-07BEB82E-E287-48A3-A03E-E6988B9FAD04Q35862776-A185CDF8-2B76-4C28-A435-FF5DF06C96DCQ36087161-B9832BEE-D983-48D3-88D3-6E3F332A99C7Q36377890-FF533B1C-B90F-486B-91C7-CAF6AE3BAC79Q36665194-4CF0239B-5745-48C0-999A-7BD6497C8E1AQ36689666-B862FB7E-F206-4A46-92F2-F60F40C1A658Q36852595-D975925F-3F0F-41CD-BA8E-AB1F027CC1C6Q36927085-AA4B2186-1715-4740-8303-EAF3288E5AE0Q37184340-59E9FEFF-B7BA-4457-BB79-20FBD05433C4Q37461492-369F9840-A9B2-4279-AC88-8A7876376893Q38342207-E1E25C4B-E38E-4734-A563-A2C35BF448B6Q38395288-6637C786-1BF2-4F1A-9702-DC3C972C3AA0Q38417631-7E798599-70A7-42E7-B241-518BF5E997AFQ38559876-E033ABD6-A36B-47FB-AFEE-F3F428685A6FQ38658672-9724E4F0-84A6-4BEF-8247-A182CDBEDEBA
P2860
Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Maintenance treatment with var ...... : a randomized clinical trial.
@ast
Maintenance treatment with var ...... : a randomized clinical trial.
@en
Maintenance treatment with var ...... : a randomized clinical trial.
@nl
type
label
Maintenance treatment with var ...... : a randomized clinical trial.
@ast
Maintenance treatment with var ...... : a randomized clinical trial.
@en
Maintenance treatment with var ...... : a randomized clinical trial.
@nl
prefLabel
Maintenance treatment with var ...... : a randomized clinical trial.
@ast
Maintenance treatment with var ...... : a randomized clinical trial.
@en
Maintenance treatment with var ...... : a randomized clinical trial.
@nl
P2093
P2860
P50
P921
P356
P1476
Maintenance treatment with var ...... r: a randomized clinical trial
@en
P2093
A Eden Evins
Corinne Cather
David A Schoenfeld
David Ayer
Gladys N Pachas
Sarah A Pratt
P2860
P304
P356
10.1001/JAMA.2013.285113
P407
P577
2014-01-01T00:00:00Z